Hernan Valdez

878 total citations
15 papers, 678 citations indexed

About

Hernan Valdez is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Hernan Valdez has authored 15 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Hernan Valdez's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (5 papers). Hernan Valdez is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (5 papers). Hernan Valdez collaborates with scholars based in United States, Italy and Australia. Hernan Valdez's co-authors include David A. Cooper, Adriano Lazzarin, Charles B. Hicks, Sharon Walmsley, Pedro Cahn, Christine Katlama, Bonaventura Clotet, Margaret Johnson, Douglas L. Mayers and Dietmar Neubacher and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Hernan Valdez

15 papers receiving 647 citations

Peers

Countries citing papers authored by Hernan Valdez

Since Specialization

Citations

This map shows the geographic impact of Hernan Valdez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernan Valdez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernan Valdez more than expected).

Fields of papers citing papers by Hernan Valdez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hernan Valdez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernan Valdez. The network helps show where Hernan Valdez may publish in the future.

Co-authorship network of co-authors of Hernan Valdez

This figure shows the co-authorship network connecting the top 25 collaborators of Hernan Valdez. A scholar is included among the top collaborators of Hernan Valdez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hernan Valdez. Hernan Valdez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Pietro Vernazza, Cunshan Wang, Anton Pozniak, (unknown), (unknown), David A. Cooper, Richard Kaplan, Adriano Lazzarin, Hernan Valdez, James Goodrich, Julie Mori, Charles Craig, Margaret Tawadrous	25
2	Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk 2008 ·PLoS ONE ·Pablo Tebas, (unknown), Roy M. Matining, (unknown), John L. Schmitz, Hernan Valdez, Nasreen C. Jahed, Laurie Myers, William G. Powderly, David Katzenstein	53
3	Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores 2007 ·AIDS ·Sharon Walmsley, Laurent Cotte, Stefano Rusconi, Douglas Ward, Charles B. Hicks, Ulrich Meier, Hernan Valdez, Charles A. Boucher	8
4	Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART 2007 ·Journal of the International Association of Physicians in AIDS Care ·Benigno Rodríguez, Hernan Valdez, Anne Mijch, Kerrie Watson, Michael M. Lederman, Grace A. McComsey, (unknown), Ian Woolley	12
5	Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir 2007 ·Antimicrobial Agents and Chemotherapy ·Linzhi Chen, John P. Sabo, (unknown), Yan‐Ping Mao, Stephen H. Norris, Thomas R. MacGregor, (unknown), (unknown), (unknown), (unknown), Hernan Valdez	18
6	Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials 2006 ·The Lancet ·Charles B. Hicks, Pedro Cahn, David A. Cooper, Sharon Walmsley, Christine Katlama, Bonaventura Clotet, Adriano Lazzarin, Margaret Johnson, Dietmar Neubacher, Douglas L. Mayers, Hernan Valdez	242
7	Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals 2005 ·AIDS ·(unknown), (unknown), Hernan Valdez, Bernhard O. Boehm, Richard B. Pollard, Ronald T. Mitsuyasu, (unknown), Michael M. Lederman, Paul Lehmann, Magdalena Tary‐Lehmann	11
8	Effect of Antioxidants on Glucose Metabolism and Plasma Lipids in HIV-Infected Subjects With Lipoatrophy 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Grace A. McComsey, (unknown), Barbara Gripshover, Robert A. Salata, Hernan Valdez	15
9	Role of Baseline pol Genotype in HIV-1 Fitness Evolution 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jan Weber, Héctor R. Rangel, Bikram Chakraborty, Michael Marotta, Hernan Valdez, Katrien Fransen, Éric Florence, Elizabeth Connick, Kimberly Y. Smith, Robert Colebunders, Alan Landay, Daniel R. Kuritzkes, Michael M. Lederman, Guido Vanham, Miguel E. Quiñones‐Mateu	18
10	Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects 2002 ·AIDS ·Raymond T. Chung, Scott Evans, Yijun Yang, Dickens Theodore, Hernan Valdez, Rebecca A. Clark, Cecilia M. Shikuma, Thomas Nevin, Kenneth E. Sherman	131
11	Genotypic Drug Resistance and Cause of Death in HIV-Infected Persons Who Died in 1999 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Douglas L. Mayers, Christoph Lange, Hernan Valdez, (unknown), Lori Lemonnier, (unknown), Michael M. Lederman	3
12	Nelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV Infection 2001 ·New England Journal of Medicine ·Mary Albrecht, Ronald J. Bosch, Scott M. Hammer, (unknown), Harold A. Kessler, Michael F. Para, Joseph J. Eron, Hernan Valdez, Marjorie Dehlinger, David Katzenstein	94
13	ELISPOT Analysis of Hepatitis C Virus Protein-Specific IFN-γ-Producing Peripheral Blood Lymphocytes in Infected Humans with and without Cirrhosis 2001 ·Clinical Immunology ·Donald D. Anthony, Anthony B. Post, Hernan Valdez, Darrell L. Peterson, (unknown), Peter S. Heeger	36
14	Mycobacterium avium Complex Osteomyelitis in HIV-Infected Patients 1997 ·Infectious Diseases in Clinical Practice ·Hernan Valdez, Barbara Gripshover, Michael D. Stover, Robert A. Salata	2
15	Effects of halothane anesthesia on equine liver function 1984 ·American Journal of Veterinary Research ·(unknown), Nicholas H. Dodman, Gary E. Hartman, Hernan Valdez, William Spivak	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact